What is Thymosin Alpha-1?
Immune-modulating peptide approved in some countries.
Thymosin Alpha-1 (Zadaxin) is a thymic peptide approved in multiple countries (not US) for immune support in hepatitis and cancer. It has more clinical data than many research peptides.
What the evidence says
The overall evidence grade for Thymosin Alpha-1 is B (moderate — mixed or smaller trials, reasonable mechanistic support). Approved in multiple countries. Clinical trial data exists.
Specific findings with supporting evidence:
- Approved in some countries for immune support. Evidence grade A.
- Shows immune-modulating effects. Evidence grade B.
Best-supported outcomes:
- Immune support under medical supervision.
Where marketing outpaces evidence:
- The claim that "FDA approved in US" is not supported by the evidence (grade A).
- Marketing often overstates: Cures immune disorders.
- Marketing often overstates: Safe for self-use.
Dose and timing
Take it in the morning. Medical supervision required.
Who it's for, and who should skip it
Most relevant for:
- Those under medical supervision in countries where approved.
Not appropriate for:
- Self-experimenters.
Safety and cautions
Caution: Not FDA approved. Approved elsewhere but not in US. Important: Medical supervision. Should be used under medical care.
Common mistakes
- Self-administering without guidance.
- Using for unproven indications.
Myths vs reality
A common misconception: TA1 is a general immune booster anyone can use. In reality, it has specific approved indications requiring medical supervision.
How it interacts with other compounds
- Thymosin Alpha-1 works well alongside tb 500 — both thymic peptides.
Questions people ask
Where is Thymosin Alpha-1 approved? Multiple countries including some in Asia and Europe, but not the US.
Editorial note
This guide summarizes the published evidence on Thymosin Alpha-1. It is educational content, not medical advice. Confirm with your clinician if you take prescription medications or manage a chronic condition.